Skip to content

Evaluation and analysis of stroke patients using SMART Board

Correlation analysis between kinematic data from SMART Board and clinical measurement

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0007122
Enrollment
130
Registered
2022-03-25
Start date
2022-03-14
Completion date
Unknown
Last updated
2022-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Others : The inertial measurement unit (IMU) sensors are attached to the patients' sternum, shoulder, upper arm, lower arm, and hand muscles for collecting kinematic data. The evaluation is performed

Sponsors

National Rehabilitation Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Patients with stroke due to one-sided infarction or hemorrhagic 2) One-sided upper extremity dysfunction 3) A person who has understood the description of the experiment and has agreed to participate by himself

Exclusion criteria

Exclusion criteria: 1)having neurological pain or muscle atrophy before the stroke 2) Severe spasticity (more than 3 grade in Modified Ashworth Scale) 3) Unable to communicate such as aphasia 4) Having a skin-related disease or open wounded. 5) Fracture or osteoporosis. 6) Diseases or injuries related soft tissue or amputation in upper limb. 7) Unable to maintain seating position for 10 minutes

Design outcomes

Primary

MeasureTime frame
THe kinematic data from the SMART Board System

Secondary

MeasureTime frame
Fugl-Meyer Assessment Upper extremity ;Action research arm test ;Active Range of motion(Shoulder flexion/extension, abduction/adduction, internal/external rotation, Elbow flexion/extension);Modified Ashworth Scale (Elbow flexion/extension);Brunnstrom stage of upper extremity;Stroke Impact Scale 3.0

Countries

Korea, Republic of

Contacts

Public ContactYeajin Ham

National Rehabilitation Center

aqualla@naver.com@aqualla@naver.com+82-2-901-1813

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026